HK13097A - Pharmaceutical preparation and process for its manufacture - Google Patents

Pharmaceutical preparation and process for its manufacture Download PDF

Info

Publication number
HK13097A
HK13097A HK13097A HK13097A HK13097A HK 13097 A HK13097 A HK 13097A HK 13097 A HK13097 A HK 13097A HK 13097 A HK13097 A HK 13097A HK 13097 A HK13097 A HK 13097A
Authority
HK
Hong Kong
Prior art keywords
tablet
film
preparation according
clodronate
dissolves
Prior art date
Application number
HK13097A
Other languages
German (de)
English (en)
French (fr)
Inventor
Posti Juhani
Katila Kirsi
Rantala Pertti
Original Assignee
Leiras Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leiras Oy filed Critical Leiras Oy
Publication of HK13097A publication Critical patent/HK13097A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
HK13097A 1992-04-24 1997-02-05 Pharmaceutical preparation and process for its manufacture HK13097A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9201299A SE501389C2 (sv) 1992-04-24 1992-04-24 Farmaceutiskt preparat och förfarande för dess framställning
PCT/FI1993/000166 WO1993021907A1 (en) 1992-04-24 1993-04-21 Pharmaceutical preparation and process for its manufacture

Publications (1)

Publication Number Publication Date
HK13097A true HK13097A (en) 1997-02-14

Family

ID=20386054

Family Applications (1)

Application Number Title Priority Date Filing Date
HK13097A HK13097A (en) 1992-04-24 1997-02-05 Pharmaceutical preparation and process for its manufacture

Country Status (21)

Country Link
US (1) US5525354A (enExample)
EP (1) EP0637236B1 (enExample)
JP (1) JP3536106B2 (enExample)
AT (1) ATE143802T1 (enExample)
AU (1) AU671830B2 (enExample)
CA (1) CA2134196C (enExample)
CZ (1) CZ282871B6 (enExample)
DE (2) DE637236T1 (enExample)
DK (1) DK0637236T3 (enExample)
EE (1) EE03107B1 (enExample)
ES (1) ES2094539T3 (enExample)
FI (1) FI110667B (enExample)
GR (1) GR3022249T3 (enExample)
HK (1) HK13097A (enExample)
HU (1) HU219342B (enExample)
IL (1) IL105403A (enExample)
NO (1) NO306654B1 (enExample)
RU (1) RU2116074C1 (enExample)
SE (1) SE501389C2 (enExample)
TW (1) TW273515B (enExample)
WO (1) WO1993021907A1 (enExample)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6406714B1 (en) 1992-12-02 2002-06-18 Merck & Co., Inc. Dry mix formulation for bisphosphonic acids
ATE128363T1 (de) * 1993-05-15 1995-10-15 Boehringer Mannheim Gmbh Tablette mit verbesserter bioverfügbarkeit enthaltend dichlormethylendiphosphonsäure als wirkstoff.
US5431920A (en) * 1993-09-21 1995-07-11 Merck Frosst, Canada, Inc. Enteric coated oral compositions containing bisphosphonic acid antihypercalcemic agents
FI94926C (fi) * 1993-11-12 1995-11-27 Leiras Oy Menetelmä klodronaattivalmisteen valmistamiseksi
TW390813B (en) * 1994-04-29 2000-05-21 Merck & Co Inc Wet granulation formulation for bisphosphonic acids
US20010007863A1 (en) 1998-06-18 2001-07-12 Merck & Co., Inc. Wet granulation formulation for bisphosphonic acids
FI98343C (fi) * 1995-03-21 1997-06-10 Orion Yhtymae Oy Peroraalinen formulaatio
DE19719680A1 (de) 1997-05-09 1998-11-19 Boehringer Mannheim Gmbh Verwendung von Diphosphonsäuren zur präventiven Behandlung von Spätfolgen bei Harnblasenerweiterung oder Harnblasenersatz
JPH11137208A (ja) * 1997-11-14 1999-05-25 Nikken Chem Co Ltd 口腔内速溶性固形物及びその製造方法
EP0998932A1 (de) * 1998-10-09 2000-05-10 Boehringer Mannheim Gmbh Feste pharmazeutische Darreichungsform enthaltend Diphosphonsäure oder deren Salze und Verfahren zu ihrer Herstellung
EP0998933A1 (de) * 1998-10-09 2000-05-10 Boehringer Mannheim Gmbh Verfahren zur Herstellung von bisphosphonathaltigen pharmazeutischen Zusammensetzungen zur oralen Applikation
DE60038097T2 (de) * 1999-02-22 2009-02-12 Merrion Research I Ltd. Feste orale dosierungsform enthaltend einen resorptionsverstärker
US7658938B2 (en) 1999-02-22 2010-02-09 Merrion Reasearch III Limited Solid oral dosage form containing an enhancer
SE9901272D0 (sv) * 1999-04-09 1999-04-09 Astra Ab New improved formulation
PE20011065A1 (es) 2000-02-01 2001-11-21 Procter & Gamble Proceso para fabricar bisfosfonatos geminales
US6410520B2 (en) 2000-02-01 2002-06-25 The Procter & Gamble Company Selective crystallization of 3-pyridyl-1-hydroxyethylidene-1, 1-bisphosphonic acid sodium as the hemipentahydrate or monohydrate
WO2002070438A2 (en) * 2001-03-01 2002-09-12 Emisphere Technologies, Inc. Compositions for delivering bisphosphonates
WO2002092616A1 (en) 2001-05-11 2002-11-21 Orasense, Ltd. Antisense permeation enhancers
US20030070584A1 (en) * 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing cellulose ethers
AU4061702A (en) * 2001-05-15 2003-04-03 Mcneil-Ppc, Inc. Dip coating compositions containing starch or dextrin
US8309118B2 (en) * 2001-09-28 2012-11-13 Mcneil-Ppc, Inc. Film forming compositions containing sucralose
US7429619B2 (en) * 2002-08-02 2008-09-30 Mcneil Consumer Healthcare Polyacrylic film forming compositions
US20080287400A1 (en) 2004-05-24 2008-11-20 Richard John Dansereau Low Dosage Forms Of Risedronate Or Its Salts
US7645459B2 (en) 2004-05-24 2010-01-12 The Procter & Gamble Company Dosage forms of bisphosphonates
US20080286359A1 (en) 2004-05-24 2008-11-20 Richard John Dansereau Low Dosage Forms Of Risedronate Or Its Salts
US7645460B2 (en) 2004-05-24 2010-01-12 The Procter & Gamble Company Dosage forms of risedronate
US7862552B2 (en) * 2005-05-09 2011-01-04 Boston Scientific Scimed, Inc. Medical devices for treating urological and uterine conditions
BRPI0710503A2 (pt) 2006-04-07 2011-08-16 Merrion Res Iii Ltd uso de uma composição farmacêutica, composição farmacêutica, e, forma de dosagem oral
DE102008022520A1 (de) * 2008-05-07 2009-11-12 Bayer Animal Health Gmbh Feste Arzneimittelformulierung mit verzögerter Freisetzung
US20090280169A1 (en) 2008-05-07 2009-11-12 Merrion Research Iii Limited Compositions of peptides and processes of preparation thereof
WO2011120033A1 (en) 2010-03-26 2011-09-29 Merrion Research Iii Limited Pharmaceutical compositions of selective factor xa inhibitors for oral administration
AU2012204213A1 (en) 2011-01-07 2013-06-13 Merrion Research Iii Limited Pharmaceutical compositions of iron for oral administration
JP7211704B2 (ja) 2015-01-29 2023-01-24 ノヴォ ノルディスク アー／エス Ｇｌｐ－１アゴニスト及び腸溶コーティングを含む錠剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57171428A (en) * 1981-04-13 1982-10-22 Sankyo Co Ltd Preparation of coated solid preparation
ES2040733T3 (es) * 1986-12-20 1993-11-01 Boehringer Mannheim Gmbh Medicamentos que contienen clodronato y procedimiento para su preparacion.
EP0313845A1 (en) * 1987-09-29 1989-05-03 Warner-Lambert Company Stabilization of enteric coated dosage form
FR2629716B1 (fr) * 1988-04-07 1991-07-19 Sanofi Sa Composition pharmaceutique pour administration orale a base d'un derive d'acide diphosphonique

Also Published As

Publication number Publication date
CA2134196A1 (en) 1993-11-11
CA2134196C (en) 2004-02-10
EP0637236A1 (en) 1995-02-08
CZ282871B6 (cs) 1997-11-12
EE03107B1 (et) 1998-08-17
SE9201299L (sv) 1993-10-25
GR3022249T3 (en) 1997-04-30
ATE143802T1 (de) 1996-10-15
TW273515B (enExample) 1996-04-01
JPH07505898A (ja) 1995-06-29
NO306654B1 (no) 1999-12-06
SE501389C2 (sv) 1995-01-30
DE69305335D1 (de) 1996-11-14
AU3955093A (en) 1993-11-29
HUT74572A (en) 1997-01-28
NO944001D0 (no) 1994-10-21
AU671830B2 (en) 1996-09-12
CZ261494A3 (en) 1995-02-15
SE9201299D0 (sv) 1992-04-24
NO944001L (no) 1994-10-21
HU219342B (en) 2001-03-28
IL105403A (en) 1998-03-10
RU94045950A (ru) 1996-11-10
DE69305335T2 (de) 1997-04-30
WO1993021907A1 (en) 1993-11-11
JP3536106B2 (ja) 2004-06-07
EP0637236B1 (en) 1996-10-09
ES2094539T3 (es) 1997-01-16
FI110667B (fi) 2003-03-14
DE637236T1 (de) 1995-07-06
IL105403A0 (en) 1993-08-18
DK0637236T3 (da) 1997-03-17
US5525354A (en) 1996-06-11
RU2116074C1 (ru) 1998-07-27
HU9403067D0 (en) 1994-12-28
FI944961A0 (fi) 1994-10-21
FI944961L (fi) 1994-10-21

Similar Documents

Publication Publication Date Title
EP0637236B1 (en) Pharmaceutical preparation and process for its manufacture
US4673564A (en) Sustained release pharmaceutical composition of solid medical material
US6010718A (en) Extended release formulations of erythromycin derivatives
US4248856A (en) Sustained release pharmaceutical compositions
KR100253824B1 (ko) Hmg-coa 환원효소 억제제 화합물을 포함하는 안정화된 약학 조성물
EP0717986B1 (en) Rotor granulation and coating of acetaminophen, pseudoephedrine, chlorpheniramine, and, optionally, dextromethorphan
KR100348585B1 (ko) 다리페나신을함유하는약학제제
EP0255404B1 (en) Sustained release ibuprofen formulation
US20060039969A1 (en) Extended release formulations of erythromycin derivatives
NZ202565A (en) Oral controlled-release multiple-unit formulation with homogeneous core and gastric-resistant coating
HU196708B (en) Process for producing pharmaceutical composition comprising omeprazol and suitable for treating deseases of the digestive system
KR20010080578A (ko) 약학 혼합 제제
US20060159758A1 (en) Coating composition for taste masking coating and methods for their application and use
EP1044681B1 (en) Sustained release carbamazepine formulation
WO2008083561A1 (en) Oral pharmaceutical composition of glycyrrhizin or its salts and the preparation method thereof
US20250057777A1 (en) Intestine-Targeted Drug Delivery Compositions and Preparation Methods Thereof
US7687542B2 (en) Rapidly bioavailable tablet and capsule formulations of diclofenac
JP6328138B2 (ja) Ｎ−［５−［２−（３，５−ジメトキシフェニル）エチル］−２ｈ−ピラゾール−３−イル］−４−［（３ｒ，５ｓ）−３，５−ジメチルピペラジン−１−イル］ベンズアミドの医薬製剤
HK1027023B (en) Extended release formulations of clarithromycin
HK1151466B (en) Oral pharamaceutical composition of glycyrrhizin or its salts and the preparation method thereof

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20090421